2023-06-012024-05-312024-05-31false10796948Lopic Ltd2025-02-2578200falseiso4217:GBPxbrli:pure107969482023-06-01107969482024-05-31107969482023-06-012024-05-31107969482022-06-01107969482023-05-31107969482022-06-012023-05-3110796948bus:SmallEntities2023-06-012024-05-3110796948bus:AuditExempt-NoAccountantsReport2023-06-012024-05-3110796948bus:FullAccounts2023-06-012024-05-3110796948bus:PrivateLimitedCompanyLtd2023-06-012024-05-3110796948core:WithinOneYear2024-05-3110796948core:AfterOneYear2024-05-3110796948core:WithinOneYear2023-05-3110796948core:AfterOneYear2023-05-311079694812023-06-012024-05-3110796948core:ShareCapital2024-05-3110796948core:SharePremium2024-05-3110796948core:RevaluationReserve2024-05-3110796948core:OtherReservesSubtotal2024-05-3110796948core:RetainedEarningsAccumulatedLosses2024-05-3110796948core:ShareCapital2023-05-3110796948core:SharePremium2023-05-3110796948core:RevaluationReserve2023-05-3110796948core:OtherReservesSubtotal2023-05-3110796948core:RetainedEarningsAccumulatedLosses2023-05-3110796948core:LandBuildings2024-05-3110796948core:PlantMachinery2024-05-3110796948core:Vehicles2024-05-3110796948core:FurnitureFittings2024-05-3110796948core:OfficeEquipment2024-05-3110796948core:NetGoodwill2024-05-3110796948core:IntangibleAssetsOtherThanGoodwill2024-05-3110796948core:ListedExchangeTraded2024-05-3110796948core:UnlistedNon-exchangeTraded2024-05-3110796948core:LandBuildings2023-05-3110796948core:PlantMachinery2023-05-3110796948core:Vehicles2023-05-3110796948core:FurnitureFittings2023-05-3110796948core:OfficeEquipment2023-05-3110796948core:NetGoodwill2023-05-3110796948core:IntangibleAssetsOtherThanGoodwill2023-05-3110796948core:ListedExchangeTraded2023-05-3110796948core:UnlistedNon-exchangeTraded2023-05-3110796948core:LandBuildings2023-06-012024-05-3110796948core:PlantMachinery2023-06-012024-05-3110796948core:Vehicles2023-06-012024-05-3110796948core:FurnitureFittings2023-06-012024-05-3110796948core:OfficeEquipment2023-06-012024-05-3110796948core:NetGoodwill2023-06-012024-05-3110796948core:IntangibleAssetsOtherThanGoodwill2023-06-012024-05-3110796948core:ListedExchangeTraded2023-06-012024-05-3110796948core:UnlistedNon-exchangeTraded2023-06-012024-05-3110796948core:MoreThanFiveYears2023-06-012024-05-3110796948core:Non-currentFinancialInstruments2024-05-3110796948core:Non-currentFinancialInstruments2023-05-3110796948dpl:CostSales2023-06-012024-05-3110796948dpl:DistributionCosts2023-06-012024-05-3110796948core:LandBuildings2023-06-012024-05-3110796948core:PlantMachinery2023-06-012024-05-3110796948core:Vehicles2023-06-012024-05-3110796948core:FurnitureFittings2023-06-012024-05-3110796948core:OfficeEquipment2023-06-012024-05-3110796948dpl:AdministrativeExpenses2023-06-012024-05-3110796948core:NetGoodwill2023-06-012024-05-3110796948core:IntangibleAssetsOtherThanGoodwill2023-06-012024-05-3110796948dpl:GroupUndertakings2023-06-012024-05-3110796948dpl:ParticipatingInterests2023-06-012024-05-3110796948dpl:GroupUndertakingscore:ListedExchangeTraded2023-06-012024-05-3110796948core:ListedExchangeTraded2023-06-012024-05-3110796948dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-06-012024-05-3110796948core:UnlistedNon-exchangeTraded2023-06-012024-05-3110796948dpl:CostSales2022-06-012023-05-3110796948dpl:DistributionCosts2022-06-012023-05-3110796948core:LandBuildings2022-06-012023-05-3110796948core:PlantMachinery2022-06-012023-05-3110796948core:Vehicles2022-06-012023-05-3110796948core:FurnitureFittings2022-06-012023-05-3110796948core:OfficeEquipment2022-06-012023-05-3110796948dpl:AdministrativeExpenses2022-06-012023-05-3110796948core:NetGoodwill2022-06-012023-05-3110796948core:IntangibleAssetsOtherThanGoodwill2022-06-012023-05-3110796948dpl:GroupUndertakings2022-06-012023-05-3110796948dpl:ParticipatingInterests2022-06-012023-05-3110796948dpl:GroupUndertakingscore:ListedExchangeTraded2022-06-012023-05-3110796948core:ListedExchangeTraded2022-06-012023-05-3110796948dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-06-012023-05-3110796948core:UnlistedNon-exchangeTraded2022-06-012023-05-3110796948core:NetGoodwill2024-05-3110796948core:IntangibleAssetsOtherThanGoodwill2024-05-3110796948core:LandBuildings2024-05-3110796948core:PlantMachinery2024-05-3110796948core:Vehicles2024-05-3110796948core:FurnitureFittings2024-05-3110796948core:OfficeEquipment2024-05-3110796948core:AfterOneYear2024-05-3110796948core:WithinOneYear2024-05-3110796948core:ListedExchangeTraded2024-05-3110796948core:UnlistedNon-exchangeTraded2024-05-3110796948core:ShareCapital2024-05-3110796948core:SharePremium2024-05-3110796948core:RevaluationReserve2024-05-3110796948core:OtherReservesSubtotal2024-05-3110796948core:RetainedEarningsAccumulatedLosses2024-05-3110796948core:NetGoodwill2023-05-3110796948core:IntangibleAssetsOtherThanGoodwill2023-05-3110796948core:LandBuildings2023-05-3110796948core:PlantMachinery2023-05-3110796948core:Vehicles2023-05-3110796948core:FurnitureFittings2023-05-3110796948core:OfficeEquipment2023-05-3110796948core:AfterOneYear2023-05-3110796948core:WithinOneYear2023-05-3110796948core:ListedExchangeTraded2023-05-3110796948core:UnlistedNon-exchangeTraded2023-05-3110796948core:ShareCapital2023-05-3110796948core:SharePremium2023-05-3110796948core:RevaluationReserve2023-05-3110796948core:OtherReservesSubtotal2023-05-3110796948core:RetainedEarningsAccumulatedLosses2023-05-3110796948core:NetGoodwill2022-06-0110796948core:IntangibleAssetsOtherThanGoodwill2022-06-0110796948core:LandBuildings2022-06-0110796948core:PlantMachinery2022-06-0110796948core:Vehicles2022-06-0110796948core:FurnitureFittings2022-06-0110796948core:OfficeEquipment2022-06-0110796948core:AfterOneYear2022-06-0110796948core:WithinOneYear2022-06-0110796948core:ListedExchangeTraded2022-06-0110796948core:UnlistedNon-exchangeTraded2022-06-0110796948core:ShareCapital2022-06-0110796948core:SharePremium2022-06-0110796948core:RevaluationReserve2022-06-0110796948core:OtherReservesSubtotal2022-06-0110796948core:RetainedEarningsAccumulatedLosses2022-06-0110796948core:AfterOneYear2023-06-012024-05-3110796948core:WithinOneYear2023-06-012024-05-3110796948core:Non-currentFinancialInstrumentscore:CostValuation2023-06-012024-05-3110796948core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-012024-05-3110796948core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-012024-05-3110796948core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-012024-05-3110796948core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-012024-05-3110796948core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-012024-05-3110796948core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-012024-05-3110796948core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-012024-05-3110796948core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-012024-05-3110796948core:Non-currentFinancialInstrumentscore:CostValuation2024-05-3110796948core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-05-3110796948core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-05-3110796948core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-05-3110796948core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-05-3110796948core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-05-3110796948core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-05-3110796948core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-05-3110796948core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-05-3110796948core:Non-currentFinancialInstrumentscore:CostValuation2023-05-3110796948core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-05-3110796948core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-05-3110796948core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-05-3110796948core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-05-3110796948core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-05-3110796948core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-05-3110796948core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-05-3110796948core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-05-3110796948bus:Director12023-06-012024-05-31

Lopic Ltd

(formerly SIGNATURE HEALTHCARE RECRUITMENT LIMITED)

Registered Number
10796948
(England and Wales)

Unaudited Financial Statements for the Year ended
31 May 2024

Lopic Ltd
Company Information
for the year from 1 June 2023 to 31 May 2024

Director

SAMANI, Reece

Registered Address

6 The Marlins
Northwood
HA6 3NP

Registered Number

10796948 (England and Wales)
Lopic Ltd
Balance Sheet as at
31 May 2024

Notes

2024

2023

£

£

£

£

Current assets
Debtors36,248303
Cash at bank and on hand2,3244,910
8,5725,213
Creditors amounts falling due within one year4(240,458)(285,173)
Net current assets (liabilities)(231,886)(279,960)
Total assets less current liabilities(231,886)(279,960)
Creditors amounts falling due after one year5(49,600)(49,600)
Net assets(281,486)(329,560)
Capital and reserves
Called up share capital1,0001,000
Profit and loss account(282,486)(330,560)
Shareholders' funds(281,486)(329,560)
The financial statements were approved and authorised for issue by the Director on 25 February 2025, and are signed on its behalf by:
SAMANI, Reece
Director
Registered Company No. 10796948
Lopic Ltd
Notes to the Financial Statements
for the year ended 31 May 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Going concern
These accounts are prepared on a going concern basis given the continued support of the director.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2.Average number of employees

20242023
Average number of employees during the year11
3.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables3,000-
Other debtors3,248303
Total6,248303
4.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables5312,519
Amounts owed to related parties129,222174,213
Other creditors110,705108,441
Total240,458285,173
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
5.Creditors: amounts due after one year

2024

2023

££
Other creditors49,60049,600
Total49,60049,600
6.Related party transactions
Included in other Creditors is a balance amounting to £129,222.00 (2023: £174,213) due to Signature Healthcare Services Ltd, a company in which Mr R Samani is a director.